Revenio Group Oyj: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.
Provider: Reuters Investment Profile
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.
Revenio Group Oyj Confirms FY 2013 Guidance
Revenio Group Oyj announced that it still expects consolidated net sales (revenue) and operating profit (EBIT) excluding non-recurring items to show year-on-year growth in the fiscal year 2013. For the fiscal year 2012, the Company reported revenue of EUR 25.4 million and EBIT of EUR 4.9 million. According to I/B/E/S Estimates, analysts on average are expecting the Company to report fiscal year 2013 revenue of EUR 28.53 million and fiscal year 2013 EBIT of EUR 5.52 million.
Latest Key Developments in Advanced
- Spectranetics Corp raises FY 2014 revenue guidance; lowers FY 2014 earnings guidance
- Cerner Corporation gives Q3 2014 guidance in line with analysts' estimates; raises low end of prior FY 2014 guidance
- Cynosure Inc receives expanded FDA clearance to Market PicoSure for Treatment of Acne Scars
- MELA Sciences Inc announces new study results demonstrating improved diagnostic accuracy for resident dermatologists when utilizing MelaFind Predictive Probability Information
- Share this
- Digg this